Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 24
1946 135
1947 144
1948 176
1949 148
1950 188
1951 161
1952 189
1953 169
1954 181
1955 176
1956 168
1957 207
1958 181
1959 192
1960 205
1961 194
1962 206
1963 226
1964 263
1965 241
1966 258
1967 247
1968 232
1969 265
1970 258
1971 279
1972 285
1973 253
1974 302
1975 282
1976 291
1977 297
1978 308
1979 309
1980 339
1981 379
1982 456
1983 481
1984 561
1985 541
1986 505
1987 549
1988 567
1989 508
1990 554
1991 667
1992 629
1993 625
1994 493
1995 441
1996 463
1997 279
1998 371
1999 515
2000 380
2001 353
2002 345
2003 406
2004 410
2005 434
2006 506
2007 459
2008 440
2009 344
2010 360
2011 326
2012 321
2013 372
2014 320
2015 357
2016 335
2017 317
2018 306
2019 271
2020 312
2021 215
Text availability
Article attribute
Article type
Publication date

Search Results

24,774 results
Results by year
Filters applied: . Clear all
Page 1
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, Feldman A, D'Andréa Saba Arruda G, de Souza AS, de Albuquerque DC, Mazza L, Santos MF, Salvador NZ, Gibson CM, Granger CB, Alexander JH, de Souza OF; BRACE CORONA investigators. Lopes RD, et al. Am Heart J. 2020 Aug;226:49-59. doi: 10.1016/j.ahj.2020.05.002. Epub 2020 May 13. Am Heart J. 2020. PMID: 32502882 Free PMC article.
Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV).
Cannon CP, McGuire DK, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Charbonnel B, Shih WJ, Gallo S, Masiukiewicz U, Golm G, Cosentino F, Lauring B, Terra SG; VERTIS-CV Investigators. Cannon CP, et al. Am Heart J. 2018 Dec;206:11-23. doi: 10.1016/j.ahj.2018.08.016. Epub 2018 Sep 5. Am Heart J. 2018. PMID: 30290289 Free article. Clinical Trial.
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial.
Sarraju A, Li J, Cannon CP, Chang TI, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Greene T, Heerspink HJL, Levin A, Neal B, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Perkovic V, Jardine M, Mahaffey KW. Sarraju A, et al. Am Heart J. 2021 Mar;233:141-148. doi: 10.1016/j.ahj.2020.12.008. Epub 2020 Dec 22. Am Heart J. 2021. PMID: 33358942 Clinical Trial.
Targeted hypothermia versus targeted Normothermia after out-of-hospital cardiac arrest (TTM2): A randomized clinical trial-Rationale and design.
Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Bělohlávek J, Callaway C, Cariou A, Eastwood G, Erlinge D, Hovdenes J, Joannidis M, Kirkegaard H, Kuiper M, Levin H, Morgan MPG, Nichol AD, Nordberg P, Oddo M, Pelosi P, Rylander C, Saxena M, Storm C, Taccone F, Ullén S, Wise MP, Young P, Friberg H, Nielsen N. Dankiewicz J, et al. Am Heart J. 2019 Nov;217:23-31. doi: 10.1016/j.ahj.2019.06.012. Epub 2019 Jun 26. Am Heart J. 2019. PMID: 31473324 Free article.
24,774 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page